Same-day human papilloma virus vaccination improves vaccine uptake in a dermatology sexually transmitted infection clinic: A quality improvement-based model for improving vaccination rates.

BACKGROUND: Human papilloma virus (HPV) is a prevalent sexually transmitted infection (STI) associated with malignancies and condyloma acuminata, with significant health care costs. Despite vaccine availability, vaccination rates remain low, highlighting the need for effective interventions to increase uptake.

OBJECTIVE: To improve HPV vaccination rates among eligible individuals at a safety-net dermatology STI clinic.

METHODS: A multiphase quality improvement program aimed to improve HPV education and vaccination rates was implemented in a dermatology STI clinic. The cohort included 175 patients with condyloma acuminata between August 2019 and December 2022. HPV vaccine education and immunization rates were measured.

RESULTS: While counseling/education rates were high, vaccination initiation rates remained low before the onset of in-office HPV vaccine. In-office HPV vaccine administration demonstrated a 175% increase in vaccine initiation (P < .01).

LIMITATIONS: This study had a relatively small sample size and was conducted in an urban, safety-net hospital; results may not be generalizable to smaller or rural practices.

CONCLUSION: This quality improvement initiative successfully increased HPV vaccination rates at a safety-net dermatology STI clinic, demonstrating that in-office, same day vaccination for HPV was critical for the success. Our study highlights an effective approach toward improving vaccination rates for HPV and is a model for vaccine delivery.